Reinhard Depping

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Long Non Coding Rna

Cell Cycle Arrest

Genome Wide Analysis

Induced Pluripotent Stem Cells

Top Venues

OncoTargets and therapy

Journal of cancer research and clinical oncology

International journal of endocrinology

Cancer cell international

This page only lists publications with an associated author ORCID identifier.

Publications

Mete Ozkurt, Thomas Hellwig-Bürgel, Reinhard Depping, Selda Kadabere, Rumeysa Özyurt, Abdullah Karadag, Nilufer Erkasap
miR663 Prevents Epo Inhibition Caused by TNF-Alpha in Normoxia and Hypoxia. International journal of endocrinology 2021 (2021)
Moritz von Fallois, Friederike Katharina Kosyna, Markus Mandl, Yosef Landesman, Jürgen Dunst, Reinhard Depping
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity. Journal of cancer research and clinical oncology 147 (7) (2021)
Reinhard Depping, Moritz von Fallois, Yosef Landesman, Friederike Katharina Kosyna
The Nuclear Export Inhibitor Selinexor Inhibits Hypoxia Signaling Pathways And 3D Spheroid Growth Of Cancer Cells. OncoTargets and therapy 12 (2019)
Markus Mandl, Reinhard Depping
ARNT is a potential direct HIF-1 target gene in human Hep3B hepatocellular carcinoma cells. Cancer cell international 17 (2017)